Cargando…
The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells
BACKGROUND: Glucocorticoids (GCs) cause apoptosis in malignant cells of lymphoid lineage by transcriptionally regulating a plethora of genes. As a result, GCs are included in almost all treatment protocols for lymphoid malignancies, particularly childhood acute lymphoblastic leukemia (chALL). The mo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133055/ https://www.ncbi.nlm.nih.gov/pubmed/25103118 http://dx.doi.org/10.1186/1471-2164-15-662 |
_version_ | 1782330711198400512 |
---|---|
author | Bindreither, Daniel Ecker, Simone Gschirr, Barbara Kofler, Anita Kofler, Reinhard Rainer, Johannes |
author_facet | Bindreither, Daniel Ecker, Simone Gschirr, Barbara Kofler, Anita Kofler, Reinhard Rainer, Johannes |
author_sort | Bindreither, Daniel |
collection | PubMed |
description | BACKGROUND: Glucocorticoids (GCs) cause apoptosis in malignant cells of lymphoid lineage by transcriptionally regulating a plethora of genes. As a result, GCs are included in almost all treatment protocols for lymphoid malignancies, particularly childhood acute lymphoblastic leukemia (chALL). The most commonly used synthetic GCs in the clinical setting are prednisolone and dexamethasone. While the latter has a higher activity and more effectively reduces the tumor load in patients, it is also accompanied by more serious adverse effects than the former. Whether this difference might be explained by regulation of different genes by the two GCs has never been addressed. RESULTS: Using a recently developed GC bioassay based on a GC-responsive reporter construct in human Jurkat T-ALL cells, we found ~7-fold higher biological activity with dexamethasone than prednisolone. Similarly, 1.0e-7 M dexamethasone and 7.0e-7 M prednisolone triggered similar cell death rates in CCRF-CEM-C7H2 T-chALL cells after 72 hours of treatment. Using microarray-based whole genome expression profiling and a variety of statistical and other approaches, we compared the transcriptional response of chALL cells to 6 hour exposure to both synthetic GCs at the above concentrations. Our experiments did not detect any gene whose regulation by dexamethasone differed significantly from that by prednisolone. CONCLUSIONS: Our findings suggest that the reported differences in treatment efficacy and cytotoxicity of dexamethasone and prednisolone are not caused by inherent differences of the 2 drugs to regulate the expression of certain genes, but rather result either from applying them in biologically in-equivalent concentrations and/or from differences in their pharmacokinetics and - dynamics resulting in different bioactivities in tumor cells and normal tissues. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-662) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4133055 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41330552014-08-18 The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells Bindreither, Daniel Ecker, Simone Gschirr, Barbara Kofler, Anita Kofler, Reinhard Rainer, Johannes BMC Genomics Research Article BACKGROUND: Glucocorticoids (GCs) cause apoptosis in malignant cells of lymphoid lineage by transcriptionally regulating a plethora of genes. As a result, GCs are included in almost all treatment protocols for lymphoid malignancies, particularly childhood acute lymphoblastic leukemia (chALL). The most commonly used synthetic GCs in the clinical setting are prednisolone and dexamethasone. While the latter has a higher activity and more effectively reduces the tumor load in patients, it is also accompanied by more serious adverse effects than the former. Whether this difference might be explained by regulation of different genes by the two GCs has never been addressed. RESULTS: Using a recently developed GC bioassay based on a GC-responsive reporter construct in human Jurkat T-ALL cells, we found ~7-fold higher biological activity with dexamethasone than prednisolone. Similarly, 1.0e-7 M dexamethasone and 7.0e-7 M prednisolone triggered similar cell death rates in CCRF-CEM-C7H2 T-chALL cells after 72 hours of treatment. Using microarray-based whole genome expression profiling and a variety of statistical and other approaches, we compared the transcriptional response of chALL cells to 6 hour exposure to both synthetic GCs at the above concentrations. Our experiments did not detect any gene whose regulation by dexamethasone differed significantly from that by prednisolone. CONCLUSIONS: Our findings suggest that the reported differences in treatment efficacy and cytotoxicity of dexamethasone and prednisolone are not caused by inherent differences of the 2 drugs to regulate the expression of certain genes, but rather result either from applying them in biologically in-equivalent concentrations and/or from differences in their pharmacokinetics and - dynamics resulting in different bioactivities in tumor cells and normal tissues. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-662) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-07 /pmc/articles/PMC4133055/ /pubmed/25103118 http://dx.doi.org/10.1186/1471-2164-15-662 Text en © Bindreither et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Bindreither, Daniel Ecker, Simone Gschirr, Barbara Kofler, Anita Kofler, Reinhard Rainer, Johannes The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells |
title | The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells |
title_full | The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells |
title_fullStr | The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells |
title_full_unstemmed | The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells |
title_short | The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells |
title_sort | synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133055/ https://www.ncbi.nlm.nih.gov/pubmed/25103118 http://dx.doi.org/10.1186/1471-2164-15-662 |
work_keys_str_mv | AT bindreitherdaniel thesyntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT eckersimone thesyntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT gschirrbarbara thesyntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT kofleranita thesyntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT koflerreinhard thesyntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT rainerjohannes thesyntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT bindreitherdaniel syntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT eckersimone syntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT gschirrbarbara syntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT kofleranita syntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT koflerreinhard syntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells AT rainerjohannes syntheticglucocorticoidsprednisoloneanddexamethasoneregulatethesamegenesinacutelymphoblasticleukemiacells |